Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCEPT: ONTAK + CHOP in PTCL
NCT00211185Phase 2Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Mar 2004
- Primary completion
- Aug 2008
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of denileukin diftitox in peripheral T-cell lymphoma (PTCL), sponsored by Eisai Co., Ltd.. Started Mar 2004; status: completed.
02
Drugs
denileukin diftitox
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT00211185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00211185.